Healthy men test generic vs. brand cancer drug in meal study
NCT ID NCT03050177
First seen May 26, 2026 · Last updated May 29, 2026 · Updated 1 time
Summary
This study tested whether a generic gefitinib tablet works the same as the brand-name version (Iressa) in 38 healthy Chinese men. Each participant took one dose of each version after a meal, and researchers measured drug levels in the blood. The goal was to confirm the generic is equally absorbed, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.